Has Theodore Treese received payments from drug or device companies?

Yes. Drug and device makers reported $618 in general payments to Theodore Treese across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Theodore Treese did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Theodore Treese come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Theodore Treese

Psychiatry · Boca Raton, FLNPI 1952544496

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 27.3% of the total.

$618in general payments, 2019–2025

Across 11 payments — averaging $56.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neurocrine Biosciences, Inc.$168
Teva Pharmaceuticals USA, Inc.$157
Otsuka America Pharmaceutical, Inc.$150
Alkermes, Inc.$120
Sunovion Pharmaceuticals Inc.$22

$8,544,465in research payments, 2019–2025

Across 433 payments — averaging $19,733 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sumitomo Pharma America, Inc.$3.2M
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2.5M
Teva Pharmaceuticals USA, Inc.$1.7M
Sunovion Pharmaceuticals Inc.$704K
Otsuka Pharmaceutical Development & Commercialization, Inc.$351K
Purdue Pharma L.p.$24K
plus $23K from 3 others

What the payments were for

Food & beverage$618100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neurocrine Biosciences, Inc.	1	$168
Teva Pharmaceuticals USA, Inc.	4	$157
Otsuka America Pharmaceutical, Inc.	3	$150
Alkermes, Inc.	2	$120
Sunovion Pharmaceuticals Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$618 in reported general payments places this provider in the 55th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Other psychiatry in Boca Raton

Richard JacksonBoca Raton$3.6M
Mustafa PirzadaBoca Raton$122K
Andrew CutlerLakewood Ranch$5.7M
Ilan MelnickCoral Gables$2.8M
Todd BroderSt Augustine$1.6M
Heather LuingSaint Augustine$1.5M
Todd GatesWest Melbourne$1.2M
Lawrence ReccoppaGainesville$968K
Thomas ValenteLeesburg$967K
Michelle ScargleClearwater$926K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →